Advocacy

Overview

Our advocacy working group helps ensure client interests are represented and considered as the federal government responds to the COVID-19 threat. These consultants and attorneys are engaging daily with Capitol Hill and federal agencies, leveraging decades of government and regulatory affairs experience.

Advocacy

Overview

Contact

Partner

Executive Vice President, District Policy Group

Sr Vice President, District Policy Group

Principal - Faegre Drinker Consulting

Insights

Insights

COVID-19 Weekly Newsletter: An Annual COVID-19 Booster?

COVID-19 Weekly Newsletter: Vaccine Progress Continues in U.S.

COVID-19 Weekly Newsletter: Preventing the Next Pandemic

COVID-19 Weekly Newsletter: 200M U.S. Vaccines by May — Biden’s New Goal

COVID-19 Weekly Newsletter: 116 Million Vaccines

COVID-19 Weekly Newsletter: COVID-19 Relief, Vaccine Rollout Update

February Regulatory and Legislative Update

COVID-19 Weekly Newsletter: Leaders Ponder Return to Normalcy

COVID-19 Weekly Newsletter: New Vaccines, Streamlined Shipment Coordination

COVID-19 Weekly Newsletter: Biden Announces School Reopening Goals

COVID-19 Weekly Newsletter: CDC Releases Guidance for Vaccinated Population

COVID-19 Weekly Newsletter: Vaccinations Surpass Infection Rate

Senate Republicans Offer Details on COVID-19 Relief

COVID-19 Weekly Newsletter: New Vaccines on the Horizon as COVID-19 Variants Pose Continued Challenges

Reflections on a Tumultuous 2020, and What’s in Store for Government Contractors Under the Biden Administration

COVID-19 Weekly Newsletter: Biden Administration Rolls Out COVID-19 Response

COVID-19 Weekly Newsletter: Biden Announces Ambitious Vaccination Plan

COVID-19 Weekly Newsletter: U.S. Suffers Deadliest Days for COVID-19

Congress Provides Additional Funding and Guidelines for Paycheck Protection Program in Latest Stimulus Package

Congress Passes First Major COVID-19 Relief Since April

COVID-19 Weekly Newsletter: 2.9M Vaccines Delivered, Relief Package Update

COVID-19 Weekly Newsletter: FDA Committee Recommends Vaccine Approval

COVID-19 Weekly Newsletter: Vaccine Progress Report

COVID-19 Weekly Newsletter: Vaccine Update, Thanksgiving Guidance

COVID-19 Weekly Newsletter: Positive Developments in the Race for a COVID-19 Vaccine

COVID-19 Weekly Newsletter: New Cases Climb in the U.S.

COVID-19 Weekly Newsletter: 8+ Million Cases in the U.S. and Counting

COVID-19 Weekly Newsletter: U.S. Eyes Third Wave as Scientific Understanding, FDA Actions Advance

COVID-19 Weekly Newsletter: Second Wave Hits Europe, Reinfection Cases Emerge

COVID-19 Weekly Newsletter: Vaccine Development Progresses as Cases Spike in the U.S.

The American Telemedicine Association Leads the Industry Commenting on Medicare Updates to Telehealth Policy

COVID-19 Weekly Newsletter: POTUS Tests Positive, Pharma Pushes Back on Vaccine Politics

COVID-19 Weekly Newsletter: Case Count, Death Toll Both Rising as Public Health Officials Work to Instill Confidence in a Vaccine

COVID-19 Weekly Newsletter: Researchers Study Dining Risks, Asymptomatic Transmission

COVID-19 Weekly Newsletter: Pharma Companies Sign Vaccine Pledge, Relief Package Stalls

COVID-19 Weekly Newsletter: Vaccine News, New Findings on Long-Term Effects of COVID-19

Senate Republicans Plan to Release ‘Skinny’ COVID-19 Plan

COVID-19 Weekly Newsletter: CDC Changes Guidance, U.S. Case Trends and New Scientific Developments

COVID-19 Weekly Newsletter: Back-to-School Snags, Research Breakthroughs

COVID-19 Weekly Newsletter: Questions Swirl Around Federal Response, Back-to-School Plans as COVID-19 Studies Continue

COVID-19 Weekly Newsletter: Vaccine Update, New Tests and Tracing Efforts

Health Care Amid and After COVID-19: Public Policy Outlook

Senate Republicans Introduce COVID-19 Relief Proposals: How Does It Compare to Democrats’ Priorities?

U.S. Congress Steps Up Oversight of COVID-19 Response

The COVID-19 Toolkit: What Businesses Need to Know as States Reopen

Paycheck Protection Program Flexibility Act Passes, Increasing PPP Accessibility for Businesses

Congress Moves on Flexibility Act in Latest Paycheck Protection Program Development

Paycheck Protection Program: Loan Forgiveness Guidance

The HEROES Act: Policy Overview and Political Prospects for the Latest COVID-19 Relief Bill

Latest Developments on Paycheck Protection Program “Certification”

Tracking Telehealth Policies Implemented During the COVID-19 Public Health Emergency

Highlights of the Paycheck Protection Program and Health Care Enhancement Act

Congress Closer to Expanding Popular CARES Act Programs

Minnesota Legislative Update: Legislature Reconvenes

Minnesota Legislative Update: Governor Extends Stay at Home Order

Opportunities for Small Businesses Through the Federal Stimulus Bill and Current SBA Loan Program

Minnesota Legislative Update: COVID-19 Response Continues

Congress Nears Passage of $2 Trillion COVID-19 Relief Package

On To Phase Three: A Third Supplemental Package Is Aimed at Curbing the Economic Downturn From COVID-19

Minnesota Legislative Update: COVID-19 Emergency Measures

A Day in Telehealth History: Access to Telehealth Services Expanded, Requirements to Facilitate Virtual Visits Relaxed in Response to Coronavirus

Congress Passes Expansive Coronavirus Package, Including Paid Leave

Congress Considers Expansive Coronavirus Package, Including Paid Leave and Free Testing

Special Update: Minnesota Legislature Recesses

President Donald Trump Declared a National Emergency to Combat Coronavirus – What Happens Now?

Congress Sends $8.3B Coronavirus Package to the President — What Does That Mean for You?

COVID-19 Resource Center Home